Rosette formation in relation to active synthesis of antibody.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation; D000921:Antibody-Producing Cells; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D000941:Antigens; D001152:Arsenicals / Q000494:pharmacology; D001665:Binding Sites; D002462:Cell Membrane / Q000276:immunology; D002499:Centrifugation, Density Gradient; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D006041:Goats; D006462:Hemolytic Plaque Technique; D007120:Immunochemistry; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007461:Iodoacetates / Q000494:pharmacology; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D051379:Mice; D011691:Puromycin / Q000494:pharmacology; D012756:Sheep; D012760:Shigella / Q000276:immunology; D012964:Sodium; D013154:Spleen / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D000941:Antigens; D001152:Arsenicals; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007461:Iodoacetates; D003609:Dactinomycin; D011691:Puromycin; D008623:Mercaptoethanol; D003513:Cycloheximide; D012964:Sodium